Transportation & Logistics Industry Today

Pharmaceutical 3PL Market to Reach USD 97.94 Billion by 2030, Driven by Cold-Chain Expansion and Real-Time Monitoring Technologies

Mordor Intelligence has published a latest report on the Pharmaceutical 3PL Market, offering a comprehensive analysis of trends, growth drivers, and future projections
Published 10 October 2025

According to Mordor Intelligence, the pharmaceutical 3PL market size stands at USD 68.03 billion in 2025 and is projected to reach USD 97.94 billion by 2030, advancing at a 7.56% CAGR. his growth is fueled by the widening distribution of temperature-sensitive drugs, stricter global distribution regulations, and expanding outsourcing needs from small and mid-sized pharmaceutical manufacturers. 

As the demand for specialty biologics and cell-based therapies accelerates, logistics providers are investing heavily in cryogenic infrastructure and ultra-cold storage solutions. Digitalization across the supply chain, including IoT-enabled monitoring, is enhancing shipment visibility and compliance with regulatory standards. 

Pharmaceutical 3PL Market Segmentation 

  • By Service Type & Temperature: Includes domestic and international transportation management, warehousing, and packaging services, segmented into cold chain and non-cold chain logistics. 
  • By End User & Product Type: Serves pharmaceutical manufacturers, wholesalers, and healthcare providers; products include prescription drugs, vaccines, cell and gene therapies, and biologics across global regions, North America, Europe, Asia-Pacific, South America, and the Middle East. 

Key Trends Shaping the Market 

  • Rising Specialty Biologics: Increasing demand for biologic and cell-based drugs is pushing 3PL providers to strengthen cold-chain and cryogenic handling infrastructure. 
  • SME Outsourcing Growth: Small and medium pharmaceutical companies in emerging regions are increasingly relying on 3PL services to manage distribution complexity. 
  • Regulatory Compliance: Implementation of stricter Good Distribution Practice (GDP) standards is accelerating adoption of real-time shipment monitoring and temperature-tracking systems. 
  • E-Pharmacy Expansion: The surge in e-pharmacy networks has increased the need for last-mile temperature-controlled deliveries, especially in densely populated urban regions. 

Pharmaceutical 3PL Market Key Players 

  • DHL Supply Chain and Global Forwarding 
  • Kuehne + Nagel International AG 
  • UPS Healthcare 
  • FedEx Logistics 
  • DB Schenker 
  • Nippon Express Co., Ltd. 

These companies play a central role in the Pharmaceutical 3PL Market, focusing on expanding temperature-controlled logistics infrastructure, enhancing digital tracking systems, and partnering with pharmaceutical manufacturers to strengthen healthcare-dedicated distribution networks worldwide. 

Dominating Country 

The United States holds a dominant position in the Pharmaceutical 3PL Market, thanks to its advanced biopharma industry, well-developed cold-chain infrastructure, and tight regulatory framework that demands high standards of quality and traceability. U.S. logistics companies were early to adopt digital temperature monitoring and data analytics to support complex biologics and vaccine distribution. The presence of many leading 3PL players and biotechnology firms further consolidates its role as a global logistics hub. As new therapies and vaccine programs grow, the U.S. market continues to attract investments and drive best practices adopted globally. 

Future Outlook 

The Pharmaceutical 3PL Market is set for steady expansion through 2030 as healthcare logistics evolves into a highly specialized, technology-driven segment. The combination of rising biologics production, complex global distribution requirements, and expanding e-pharmacy channels is redefining how pharmaceuticals are stored, handled, and delivered. Third-party logistics providers are investing heavily in digital monitoring tools, cryogenic facilities, and region-specific cold-chain hubs to maintain quality and compliance from plant to patient 

Get the latest industry insights on the pharmaceutical third-party logistics market: https://www.mordorintelligence.com/industry-reports/global-pharmaceutical-3pl-market?utm_source=Industrytoday.co.uk 

Explore related reports from Mordor Intelligence 

Japan Pharmaceutical 3PL Market: https://www.mordorintelligence.com/industry-reports/japan-pharmaceutical-3pl-market?utm_source=Industrytoday.co.uk  

Germany Pharmaceutical 3PL Market: https://www.mordorintelligence.com/industry-reports/germany-pharmaceutical-3pl-market?utm_source=Industrytoday.co.uk  

US Pharmaceutical 3PL Market: https://www.mordorintelligence.com/industry-reports/united-states-pharmaceutical-3pl-market?utm_source=Industrytoday.co.uk  

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking actionable market insights. With 550+ domain experts and specialists across 150+ countries, we deliver comprehensive syndicated and custom research across industries such as aerospace, agriculture, chemicals, consumer goods, energy, healthcare, and many more, helping organizations make informed decisions and achieve strategic goals. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com

https://www.mordorintelligence.com/ 

Other Industry News

Ready to start publishing

Sign Up today!